Abbott Laboratories Debt 2024

Abbott Laboratories Aktienanalyse

What does Abbott Laboratories do?

Abbott Laboratories is one of the largest companies in the healthcare industry worldwide. The company was founded in 1888 by Dr. Wallace C. Abbott, who aimed to develop innovative and high-quality medical products that would improve people's lives and treat illnesses. Abbott Laboratories' business model is based on the discovery, development, manufacturing, and marketing of healthcare products. These range from pharmaceuticals to diagnostic devices. The company operates in various areas, including pharmaceuticals, nutrition, diagnostics, medical technology, and animal health. In the pharmaceutical field, Abbott Laboratories is a leading provider of generic drugs as well as innovative medications specialized in treating conditions such as Parkinson's disease, cancer, or hypertension. The company is particularly known for developing medications focused on the medical needs of women, such as hormone replacement therapy or birth control pills. In the nutrition field, Abbott Laboratories leads in the development of food and supplements for specific target groups, such as premature infants, cancer patients, or those with digestive problems. Best-selling products include Similac baby formula and Ensure, a nutritional supplement for older adults. In the diagnostics field, Abbott Laboratories develops and manufactures medical diagnostic devices and systems for patient monitoring. This includes blood glucose meters, blood pressure monitors, test strips, and laboratory systems for diagnosing diseases such as diabetes, HIV, or hepatitis. Abbott Laboratories is also a significant player in the medical technology field. The company produces and distributes medical devices such as pacemakers, stents, or artificial joints. These are typically used by doctors and hospitals to optimize patient treatment. In the animal health field, Abbott Laboratories offers a wide range of products and services for agricultural farms and veterinarians. This includes animal medications, pet food, diagnostics, and other services aimed at maintaining the health and well-being of livestock. Over the years, Abbott Laboratories has received numerous awards for its products and achievements. The company is committed to improving the quality of life for people worldwide and contributes to optimizing healthcare. Abbott Laboratories is among the top 15 leading pharmaceutical and healthcare companies worldwide and currently employs around 103,000 people in over 160 countries. Abbott Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Abbott Laboratories's Debt Structure

Abbott Laboratories's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Abbott Laboratories's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Abbott Laboratories’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Abbott Laboratories’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Abbott Laboratories Stock

What is the debt of Abbott Laboratories this year?

Abbott Laboratories has a debt level of 7,783 USD this year.

What was the debt of Abbott Laboratories compared to the previous year?

The debt of Abbott Laboratories has increased by 12.94% compared to the previous year increased.

What are the consequences of high debt for investors in Abbott Laboratories?

High debt can pose a risk for investors of Abbott Laboratories, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Abbott Laboratories?

Low debt means that Abbott Laboratories has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Abbott Laboratories affect the company?

An increase in debt of Abbott Laboratories can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Abbott Laboratories affect the company?

A reduction in debt of Abbott Laboratories can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Abbott Laboratories?

Some factors that can influence the debt of Abbott Laboratories include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Abbott Laboratories so important for investors?

The debts of Abbott Laboratories are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Abbott Laboratories take to change the debt?

To change the debt, Abbott Laboratories can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Abbott Laboratories pay?

Over the past 12 months, Abbott Laboratories paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Abbott Laboratories is expected to pay a dividend of 2.24 USD.

What is the dividend yield of Abbott Laboratories?

The current dividend yield of Abbott Laboratories is .

When does Abbott Laboratories pay dividends?

Abbott Laboratories pays a quarterly dividend. This is distributed in the months of August, November, March, May.

How secure is the dividend of Abbott Laboratories?

Abbott Laboratories paid dividends every year for the past 25 years.

What is the dividend of Abbott Laboratories?

For the upcoming 12 months, dividends amounting to 2.24 USD are expected. This corresponds to a dividend yield of 2.09 %.

In which sector is Abbott Laboratories located?

Abbott Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Abbott Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Abbott Laboratories from 5/15/2024 amounting to 0.55 USD, you needed to have the stock in your portfolio before the ex-date on 4/12/2024.

When did Abbott Laboratories pay the last dividend?

The last dividend was paid out on 5/15/2024.

What was the dividend of Abbott Laboratories in the year 2023?

In the year 2023, Abbott Laboratories distributed 1.88 USD as dividends.

In which currency does Abbott Laboratories pay out the dividend?

The dividends of Abbott Laboratories are distributed in USD.